The Research Programme on Biomedical Informatics carries out fundamental research and technological developments on the application of advanced information technologies and computational methods in the health and life sciences. Ferran Sanz is the programme director.
The programme has a wide experience in the participation and coordination of research projects funded by the European Commission and a long tradition of collaboration with the pharmaceutical and biotech industry in the framework of R&D projects and providing services, especially developing computational methods to discover new drugs.
Researchers working on this programme are involved in pre and postgraduate teaching at the UPF, and direct the Master degree in Bioinformatics for Health Sciences.
The programme is currently organised in five research groups:
The programme coordinates jointly with Farmaindustria the Plataforma Tecnológica Española de Medicamentos Innovadores (PTEMI) and Ferran Sanz is one of the members of the Scientific Committee of the European Innovative Medicines Initiative (IMI).
The programme is recognized by the Autonomous Government of Catalonia as member of the technological innovation network (TECNIO) and is also the node for Biomedical Informatics of the Spanish Institute of Bioinformatics (INB).
The programme is located at the Biomedical Research Park of Barcelona (PRBB) where an exceptional cluster of research programmes and groups are working on Computational Biology and Biomedical Informatics. The collaboration with scientists of these groups is frequent and very productive.
The programme’s research activity has originated the creation of several spin-off companies: Pharmatools Digital Interactive Services, founded by Ferran Sanz, and Chemotargets, founded by Jordi Mestres.